Clinical and Translational Sciences Core

$240,162P30FY2013AINIH

University Of Rochester, Rochester NY

Investigators

Linked publications, trials & patents

Paper 38920641 Paper 37792561 Paper 37693630 Paper 36762930 Paper 36612908 Paper 36269602 Paper 36131068 Paper 36013463 Paper 35984396 Paper 35963584 Paper 35805743 Paper 35727723 Paper 35445991 Paper 35382688 Paper 35216023 Paper 35081116 Paper 34989645 Paper 34878435 Paper 34758831 Paper 34695441 Paper 34090915 Paper 33839311 Paper 33683893 Paper 33630200 Paper 33547350 Paper 33228721 Paper 33153264 Paper 33016926 Paper 32946568 Paper 32871411 Paper 32859664 Paper 32819189 Paper 32811669 Paper 32788605 Paper 32762398 Paper 32663904 Paper 32617533 Paper 32577626 Paper 32427100 Paper 32302325 Paper 32183695 Paper 32123636 Paper 32061722 Paper 31953703 Paper 31939069 Paper 31821044 Paper 31742407 Paper 31706357 Paper 31604645 Paper 31597455 Paper 31588162 Paper 31525692 Paper 31515268 Paper 31496683 Paper 31492585 Paper 31479446 Paper 31456909 Paper 31332062 Paper 31297684 Paper 31243456 Paper 31092576 Paper 31080171 Paper 31040011 Paper 30989696 Paper 30935408 Paper 30926296 Paper 30925906 Paper 30844996 Paper 30710170 Paper 30705245 Paper 30702442 Paper 30643416 Paper 30642925 Paper 30617749 Paper 30586719 Paper 30556132 Paper 30402824 Paper 30397066 Paper 30351168 Paper 30325063 Paper 30319926 Paper 30289818 Paper 30230068 Paper 30198385 Paper 30168363 Paper 30067407 Paper 30045629 Paper 30040227 Paper 30031293 Paper 30008509 Paper 29961805 Paper 29951864 Paper 29928721 Paper 29928719 Paper 29914960 Paper 29725192 Paper 29722041 Paper 29709783 Paper 29531320 Patent 9206479

Abstract

PROJECT SUMMARY (See instructions); The Clinical and Translational Sciences Core (CTSC; Core C) will provide key services to UR investigators to promote collaborative clinical and translational HIV/AIDS research. The objective of the Core is to efficiently provide UR HIV/AIDS investigators direct access to human subjects research, a discipline that can be dauntingly complex and time-consuming for new investigators (including early-stage investigators, investigators new to HIV/AIDS, and basic science HIV/AIDS investigators wishing to conduct translational research). It will do so by leveraging existing infrastructure, resources and expertise, at modest incremental cost, to create broad synergies that can make a major impact on clinical and translational studies. Our experience as a D-CFAR has shown that providing that access to services alone is not necessarily sufficient to encourage new investigators to undertake translational HIV/AIDS projects. This has led us to develop a highly proactive, user-oriented, innovative approach, that includes consultation, advice and even identification and recruitment of study subjects (

View original record on NIH RePORTER →